From discovery to market: The role of IP strategy in drug development

preview_player
Показать описание
With vaccine brand names still very much top-of-mind for Canadians, Gowling WLG's own Brian Kingwell and Dr. Sonia Ziesche took part in a recent online panel discussion surrounding drug development and intellectual property. The event touched on everything from identifying intellectual property during R&D to the importance of freedom to operate analysis, international filing strategies and portfolio management, and the unique industry challenges brought to light due to the COVID-19 pandemic.

This video may contain information of general interest about current legal issues, but does not give legal advice.
Рекомендации по теме